CE Mark Translation: The Key to Medical Device Success in Europe
With a total annual healthcare spending of $1.94 trillion, access to the EU healthcare market is crucial to success in the medical device industry. But in order to enter this critical market, companies need to obtain a CE Mark certifying that their medical device has passed EU requirements. Moreover, all documentation must be translated into the…
Global Implications of the CRISPR Patent Dispute
CRISPR may be one of the greatest life science inventions of the modern century. This new gene-editing system allows scientists to make precise changes in DNA, and with that coveted technology comes a bit of competition for the rights to claim it – specifically between MIT/Harvard and UC Berkeley. Recently the judges at the US Patent and…
NAFTA, Mexico & Medical Devices
On January 1, 1994, NAFTA was put into effect, eliminating trade barriers including tariffs on more than one-half of Mexico’s exports to the U.S and more than one-third of U.S. exports to Mexico. With the recent election of President Donald Trump, we are anticipating changes in U.S. trade policies with Mexico, including imports in medical…
Do Language Barriers to Research Impede Scientific Advancement?
Language barriers to research interfere with scientific progress which is in turn highly dependent on international research collaboration. The role of language in science and research collaboration is undeniable, and increased globalization has created a greater need to translate scientific research and provide access to larger international audiences. By employing professional translation and interpreting services…
Will Science Become Multilingual?
By publishing scientific works primarily in English we may be taking away from the scientific discoveries of non-English speakers, especially if professional translators do not perform the translations. But with advances in the translation industry and the decline of English users, will more scientists publish in their native language? Will this lead to multilingual versions of their…
Language Barriers in Global Patient Recruitment
Due to a number of factors including higher patient recruitment rates, clinical trials are increasingly outsourced to emerging regions – particularly Latin America, Central and Eastern Europe, and Asia. Successful international trial initiation, however, is greatly dependent on choosing the right language service partner to provide quality and accurate translation of global patient recruitment materials.
What Does The Brexit Mean for BioPharma?
The Brexit – UK’s decision to leave the EU will have a wide range of effects on the life sciences sector, from drug approvals and clinical research, to patents and trade. What will it mean for translation of official documents in the EU? Will they no longer need to be translated into English?
Zika Virus Vaccine: An East-West Collaboration
The Zika virus has recently been identified as the cause of a serious epidemic in Latin America and the Caribbean. Concern over the possibility of an international pandemic has led to a multi-national, and multi-lingual effort to develop the first candidate Zika virus vaccine to be approved for human clinical trials. As a result, translation services for clinical research…
Is China Developing New Blockbusters?
China is expected to become the world’s top R&D spender by 2019. But despite major efforts to change the country’s reputation from a generics manufacturer to a developer of global blockbusters, foreign and Chinese biotech companies alike must address several challenges.
Minorities Matter: Obtaining Proper Informed Consent Translation For U.S. LEP Populations
The number of individuals with Limited English Proficiency (LEP) is quickly on the rise in the United States. This has an impact on many aspects of the life science industry, including subject recruitment among minority populations whose native language is not English, and obtaining a proper informed consent translation services.